Predictive factors for the development of brain metastases in patients with malignant melanoma: A study by the Anatolian society of medical oncology

Journal of Cancer Research and Clinical Oncology

Volumn 140, Issue 1, 2014, Pages 151-157

  Gumusay, Ozge ^a   Coskun, Ugur ^a   Akman, Tülay ^b   Ekinci, Ahmet Siyar ^c   Kocar, Muharrem ^d   Erceleb, Özlem Balvan ^e   Yazici, Ozan ^f   Kaplan, Mehmet Ali ^g   Berk, Veli ^h   Cetin, Bulent ^a   Taskoylu, Burcu Yapar ⁱ   Yildiz, Ayhan ^j   Goksel, Gamze ^k   Alacacioglu, Ahmet ^l   Demirci, Umut ^c   Algin, Efnan ^a   Uysal, Mukremin ^m   Oztop, Ilhan ⁿ   Oksuzoglu, Berna ^c   Dane, Faysal ^d   Gumus, Mahmut ^e   Buyukberber, Suleyman ^a   more..

^a GAZI UNIVERSITY   (Turkey)

^b Balikesir State Hospital   (Turkey)

^c Dr Abdurrahman Yurtaslan Oncology Training and Research Hospital   (Turkey)

^d MARMARA UNIVERSITY   (Turkey)

^e DR LUTFI KIRDAR KARTAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^f ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^g DICLE UNIVERSITY   (Turkey)

^h ERCIYES UNIVERSITY   (Turkey)

ⁱ PAMUKKALE UNIVERSITY   (Turkey)

^j INONU UNIVERSITY   (Turkey)

^k CELAL BAYAR UNIVERSITY   (Turkey)

^l IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

^m AFYON KOCATEPE UNIVERSITY   (Turkey)

ⁿ DOKUZ EYLUL UNIVERSITY   (Turkey)

more..

Author keywords

Brain metastases; Melanoma; Predictive factors

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MIDDLE AGED; PREDICTIVE VALUE; PRIMARY TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TUMOR LOCALIZATION; ULCER; VERY ELDERLY; YOUNG ADULT;

EID: 84892670407     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-013-1553-7     Document Type: Article

References (24)

1. Agrawal S, Kane JM 3rd, Guadagnolo BA, et al. (2009) The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer 115(24):5836-5844
2. Amer MH, Al-Sarraf M, Baker LH, et al. (1978) Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 42:660-668 (Pubitemid 8405861)
3. Balch CM, Murad TM, Soong SJ, et al. (1978) A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Annu Surg 188(6):732-742
4. Ballo MT, Ross MI, Cormier JN, et al. (2006) Combined modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys 64(1):106-113 Epub 2005 Sep 22 (Pubitemid 41831216)
5. Bullard DE, Cox EB, Seigler HF (1981) Central nervous system metastases in malignant melanoma. Neurosurgery 8(1):26-30 (Pubitemid 11146127)
6. Cassel WA, Weidenheim KM, Campbell WG Jr, et al. (1986) Malignant melanoma: inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate. Cancer 57:1302-1312 (Pubitemid 16136745)
7. Eggermont AM, Suciu S, Santinami M, et al. (2008) Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet 372(9633):117-126 (Pubitemid 351952257)
8. Eggermont AM, Suciu S, Testori A, et al. (2012) Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer 48(2):218-225
9. Einhorn LH, Burgess MA, Vallejos C, et al. (1974) Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res 34(8):1995-2004
10. Eton O, Legha SS, Bedikian AY, et al. (2002) Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol 20(8):2045-2052 (Pubitemid 34408794)
11. Fife KM, Colman MH, Stevens GN, et al. (2004) Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 22(7):1293-1300 (Pubitemid 41079844)
12. Hofmann MA, Coll SH, Küchler I, et al. (2007) Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women? Dermatology 215(1):10-16 (Pubitemid 46976009)
13. Houghton AN, Balch CM (1992) Treatment for advanced melanoma. In: Balch CM, Houghton AN, Milton GW, et al. (eds) Cutaneous Melanoma. JB Lippincott, Philadelphia, pp 468-497
14. Madajewicz S, Karakousis C, West CR, et al. (1984) Malignant melanoma brain metastases. Review of roswell park memorial institute experience. Cancer 53(11):2550-2552 (Pubitemid 14102500)
15. Miller JG, Mac Neil S (1997) Gender and cutaneous melanoma. Br J Dermatol 136(5):657-665 (Pubitemid 27278070)
16. Mitchell MS (1989) Relapse in the central nervous system in melanoma patients successfully treated with biomodulators. J Clin Oncol 7(11):1701-1709 (Pubitemid 19272842)
17. Monsour PD, Sause WT, Avent JM, Noyes RD (1993) Local control following therapeutic nodal dissection for melanoma. J Surg Oncol 54(1):18-22 (Pubitemid 23280246)
18. Morton DL, Wanek L, Nizze JA, et al. (1991) Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne cancer clinic. Annu Surg 214(4):491-9; discussion 499-501
19. Nayak L, Lee EQ, Wen PY, et al. (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48-54
20. Patel JK, Didolkar MS, Pickren JW, et al. (1978) Metastatic pattern of malignant melanoma: a study of 216 autopsy cases. Am J Surg 135(6):807-810 (Pubitemid 8377329)
21. Raizer JJ, Hwu WJ, Panageas KS, et al. (2008) Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol 10(2):199-207
22. Sampson JH, Carter JH Jr, Friedman AH, et al. (1998) Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 88:11-20 (Pubitemid 28018958)
23. Stevens G, Firth I, Coates A (1992) Cerebral metastases from malignant melanoma. Radiother Oncol 23(3):185-191
24. Zakrzewski J, Geraghty LN, Rose AE, et al. (2011) Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer 117(8):1711-1720